Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative
2013; Springer Science+Business Media; Volume: 56; Issue: 2-3 Linguagem: Inglês
10.1007/s12026-013-8407-x
ISSN1559-0755
AutoresEmmanuel Coloma, Carolina Donate López, Pedro Moreno, Ricard Cervera, Gerard Espinosa,
Tópico(s)Heparin-Induced Thrombocytopenia and Thrombosis
Referência(s)